Related Experiment Video
Updated: Nov 12, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
Published on: December 16, 2016
Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate Engineering
Daisylyn Senna Tan1, Yanpu Chen2,3, Ya Gao1
1School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
Researchers engineered an enhanced POU factor (ePOU) that significantly improves the speed and efficiency of cell reprogramming. This novel factor can induce pluripotency with fewer transcription factors, accelerating cell fate transitions for potential clinical applications.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Transcription factor-driven cell fate engineering is crucial for regenerative medicine but requires enhanced efficiency and speed.
- Current methods for pluripotency induction, transdifferentiation, and forward reprogramming face limitations in clinical translation.
Purpose of the Study:
- To develop and characterize an enhanced transcription factor variant for accelerated and more efficient cell fate conversion.
- To investigate the molecular mechanisms underlying the improved reprogramming capabilities of the engineered factor.
Main Methods:
- Directed evolution involving iterative screening of pooled mutant libraries and phenotypic selection.
- Biochemical assays and genome-wide analyses to characterize the DNA binding and dimerization properties of the engineered factor.
- Comparison of the engineered factor's performance against wild-type Oct4 in pluripotency induction assays.
Main Results:
- An artificially evolved and enhanced POU factor (ePOU) was identified, demonstrating superior reprogramming speed and efficiency compared to wild-type Oct4.
- ePOU can induce pluripotency with Sox2 alone or in a three-factor cocktail (ePOU/Klf4/c-Myc) without Sox2.
- ePOU exhibits altered DNA binding preferences, increased thermodynamic stability, and prolonged persistence in cells, leading to differential gene activation and identification of novel signaling pathways involved in reprogramming.
Conclusions:
- Engineered transcription factor variants, such as ePOU, can significantly advance cell fate conversions.
- Phenotypic selection of novel factor variants is a key strategy for developing advanced biomolecules for cell reprogramming.
- The findings highlight the potential of ePOU for accelerating the establishment of the pluripotency network and its implications for clinical translation.
Related Concept Videos
Somatic to iPS Cell Reprogramming
Methods of Nuclear Reprogramming
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Introduction to Nuclear Reprogramming

